Too frequent low-dose methotrexate prescriptions: multicentre quality control and quality assurance with pre- and post-analysis
INTRODUCTION: Methotrexate is used to treat many medical conditions with medication schedules that differ widely in dosage and frequency. The high potential of erroneous too frequent low-dose methotrexate prescriptions leading to severe adverse reactions is well known; however, documentation is mainly limited to case reports. We reviewed all methotrexate prescriptions in a secondary and a tertiary care hospital to analyse the incidence of too frequent low-dose methotrexate prescriptions, and assessed the quality assurance concepts implemented.
METHODS: All nononcological low-dose methotrexate prescriptions issued for inpatients within 55 months were analysed to identify too frequent prescriptions potentially leading to harmful overdosing. Subsequently, clinical pharmacologists reviewed all new methotrexate prescriptions with resulting interventions at the physician level in the tertiary care hospital. The impact of an interruptive alert displayed at methotrexate order entry was assessed in the secondary care hospital.
RESULTS: The incidence of too frequent prescriptions at the tertiary hospital was 1.6% (five medication errors and nine near misses in 888 inpatients). After introducing checks by pharmacologists, two prescription errors were intercepted during the 8 month quality assurance period. At the secondary care hospital the incidence dropped from 2.5% (2/79, 20 months) to 0.8% (1/123, 35 months) after the alert was implemented.
CONCLUSIONS: The incidences of erroneous too frequent low-dose methotrexate prescriptions observed at both hospitals were considered too high due to the high potential for increased morbidity, mortality and costs. Therefore, quality assurance measures were implemented and the preliminary data show a positive impact on patient safety for both approaches.
- Arnet I, Bernhardt V, Hersberger KE. Methotrexate intoxication: the pharmaceutical care process reveals a critical error. J Clin Pharm Ther. 2012;37(2):242–4.
- Moore TJ, Walsh CS, Cohen MR. Reported medication errors associated with methotrexate. Am J Health Syst Pharm. 2004;61(13):1380–4.
- Weinblatt ME. Toxicity of low dose methotrexate in rheumatoid arthritis. J Rheumatol Suppl. 1985;12(Suppl 12):35–9.
- Psoriasis-liver-methotrexate interactions. Arch Dermatol. 1973;108(1):36-42.
- Saedder EA, Brock B, Nielsen LP, Bonnerup DK, Lisby M. Identifying high-risk medication: a systematic literature review. Eur J Clin Pharmacol. 2014;70(6):637–45.
- Sinicina I, Mayr B, Mall G, Keil W. Deaths following methotrexate overdoses by medical staff. J Rheumatol. 2005;32(10):2009–11.
- Karch AM, Karch FE. A weekly dosage taken daily. Am J Nurs. 2003;103(4):64.
- Fässler EMI, Galeazzi RL. “Low dose”-Methotrexat: Nebenwirkungen und Toxizität. Schweiz Med Forum. 2003(49):1211–15.
- Department of Health/ Patient Safety and Investigations. The “never events” list 2012/13. 2012 [cited 2015 Feb 3]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/215206/dh_132352.pdf.
- Institute for Safe Medication Practices. Still Outside the Bull’s Eye: 2014-2015 Targeted Medication Safety Best Practices (Baseline Survey Results). 2014 [cited 2015 Feb 2]. Available from: http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=76.
- National Patient Safety Agency. Oral methotrexate tablets - IT requirement specification. 2006 [cited 2015 Jan 29]. Available from: http://www.nrls.npsa.nhs.uk/EasySiteWeb/getresource.axd?AssetID=60036&type=full&servicetype=Attachment.
- Patient Safety Foundation. Quick-Alert Nr. 28 Methotrexat-Intoxikation -> Vermeidung von oralen Überdosierungen. 2012 [cited 2015 Feb 3]. Available from: http://www.patientensicherheit.ch/dms/de/themen/quick-alerts/3328_Quick-Alert_Nr-28_Methotrexat_20121010_dt/3328_Quick-Alert_Nr.28_Methotrexat_20121010_dt.pdf.
- Ferner RE, Aronson JK. Clarification of terminology in medication errors: definitions and classification. Drug Saf. 2006;29(11):1011–22.
- Hewitt TA, Chreim S. Fix and forget or fix and report: a qualitative study of tensions at the front line of incident reporting. BMJ Qual Saf. 2015;24(5):303–10.
- Meier M, Giuliani F, Schneemann M. Bedeutung von CIRS für Spitäler und Hausarztpraxen. Praxis. 2015;104(5):219–26.
- Swissmedic Pharmacovigilance Centre. Pharmacovigilance. [cited 2015 May 5]. Available from: https://www.swissmedic.ch/marktueberwachung/00135/00160/index.html?lang=en.
- Institute for Safe Medication Practices. 2014-15 Targeted Medication Safety Best Practices for Hospitals (Baseline Survey Results 2014). 2014 [cited 2015 Feb 3]. Available from: http://www.ismp.org/Tools/BestPractices/TMS%20Results-040214.pdf http://www.ismp.org/Tools/BestPractices/TMS Results-040214.pdf.
- Ojeleye O, Avery AJ, Boyd MJ. Assessing the safety features of electronic patient medication record systems used in community pharmacies in England. Br J Clin Pharmacol. 2014;78(2):401–9.
- Kaushal R, Bates DW, Abramson EL, Soukup JR, Goldmann DA. Unit-based clinical pharmacists’ prevention of serious medication errors in pediatric inpatients. Am J Health Syst Pharm. 2008;65(13):1254–60.
- Bladh L, Ottosson E, Karlsson J, Klintberg L, Wallerstedt SM. Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial. BMJ Qual Saf. 2011;20(9):738–46.
- Reason J. Human error: models and management. West J Med. 2000;172(6):393–6.
- Westbrook JI, Li L, Lehnbom EC, Baysari MT, Braithwaite J, Burke R, et al. What are incident reports telling us? A comparative study at two Australian hospitals of medication errors identified at audit, detected by staff and reported to an incident system. Int J Qual Health Care. 2015;27(1):1–9.
- van Doormaal JE, van den Bemt PM, Zaal RJ, Egberts AC, Lenderink BW, Kosterink JG, et al. The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study. J Am Med Inform Assoc. 2009;16(6):816–25.
- Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998;280(15):1311–6.
- Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, et al. Guided medication dosing for inpatients with renal insufficiency. JAMA. 2001;286(22):2839–44.